EarningsQ4 2023 Earnings Report

AbbVie (ABBV) Q4 2023 Earnings Report

0 Followers

MX:ABBV Q4 2023 EPS Results

Actual EPS$50.67

Consensus EPS$50.72

Beat/MissMissed by -$0.05

One Year Ago EPS$65.38

Actual Revenue$259.73B

Expected Revenue$254.71B

Beat/MissBeat by +$5.01B

YoY Revenue Growth-5.42%

QuarterQ4 2023

Date02/02/2024

TimeBefore Open

Conference CallFriday, February 2, 2024

MX:ABBV Upcoming Earnings

AbbVie's next earnings date is estimated for October 30, 2026, based on past reporting schedules.

MX:ABBV Q4 2023 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 30, 2026	2026 (Q3)	70.08 / -	33.78	―
Jul 31, 2026	2026 (Q2)	65.47 / 66.29	53.939	22.90% (+12.35)
Apr 29, 2026	2026 (Q1)	47.07 / 48.13	44.677	7.72% (+3.45)
Feb 04, 2026	2025 (Q4)	48.18 / 49.22	39.229	25.46% (+9.99)
Oct 31, 2025	2025 (Q3)	32.07 / 33.78	54.484	-38.00% (-20.70)
Jul 31, 2025	2025 (Q2)	52.30 / 53.94	48.128	12.08% (+5.81)
Apr 25, 2025	2025 (Q1)	43.21 / 44.68	41.953	6.49% (+2.72)
Jan 31, 2025	2024 (Q4)	38.41 / 39.23	50.67	-22.58% (-11.44)
Oct 30, 2024	2024 (Q3)	53.03 / 54.48	53.576	1.69% (+0.91)
Jul 25, 2024	2024 (Q2)	46.60 / 48.13	52.85	-8.93% (-4.72)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed